AstraZeneca PLC | Reg No. 02723534 | SIC Code 2441 | HQ London | Tel 0207 3045000 | Turnover £20,313.0m | Employees 66600 | Locations 22 | 97 Company Alerts | 14 Subsidiary Alerts
AstraZeneca cheered investors as it doubled the value of its share buyback scheme, raised its full-year profits forecast and confirmed that a key new drug was close to being approved.
29 Jul 2010
AstraZeneca's good results boosted by US backing for Brilinta - view original
AstraZeneca PLC | Reg No. 02723534 | SIC Code 2441 | HQ London | Tel 0207 3045000 | Turnover £20,313.0m | Employees 66600 | Locations 22 | 97 Company Alerts | 14 Subsidiary Alerts
Blood-thinning treatment is given green light in America as profits forecast rises
29 Jul 2010
DJ Imp. Chemical Inds. FRN Variable Rate Fix - view original
Imperial Chemical Industries (ICI) PLC | Reg No. 00218019 | SIC Code 2413 | HQ London | Tel na | Turnover £435.0m | Employees 1125 | Locations 53 | 7 Company Alerts
TIDM57CT As Agent Bank, please be advised of the following rate determined on: 28/07/10 Issue ¦ Imperial Chemical Industries plc - Series 46 - US$ 30,000,000 (MTN) FRN due 29/10/2010 ISIN Number ¦ XS0...
29 Jul 2010
FRN Variable Rate Fix - London Stock Exchange - view original
London Stock Exchange Group PLC | Reg No. 05369106 | SIC Code 7415 | HQ London | Tel 02077971000 | Turnover £671.4m | Employees 1175 | Locations 1 | 107 Company Alerts | 23 Subsidiary Alerts
Imperial Chemical Industries Ltd
29 Jul 2010
Byotrol Plc - Result of AGM
29 Jul 2010
AstraZeneca PLC - Directorate Change
29 Jul 2010
Strong quarter for AstraZeneca as FDA panel backs Brilinta
29 Jul 2010
AstraZeneca strong performer
29 Jul 2010
Chemicals maker BASF sees Q2 earnings triple
29 Jul 2010
AstraZeneca ups guidance as profits rise | Digital Look
29 Jul 2010
AstraZeneca PLC - Second Quarter and Half Year Results (Part 1 of 3)
29 Jul 2010
Antisoma's preliminary results for the year ended 30 June 2010
29 Jul 2010
Vernalis Plc - Interim results for six months ended 30 June 2010
28 Jul 2010
Belfast iPad app set to benefit drug industry
28 Jul 2010
PhRMA Asks FDA To Be More Straightforward On Safeguards It Wants To Fight Drug Risks
28 Jul 2010
Teva earnings soar yet again, driven by Copaxone
28 Jul 2010
Synergy Health on track
28 Jul 2010
Synergy Health on track | Digital Look
28 Jul 2010
Proximagen Group PLC - Half Yearly Report
28 Jul 2010
Mediwatch plc - Half Yearly Report
28 Jul 2010
Cussons in a froth as Imperial Leather maker posts raised profits
28 Jul 2010
Margin lift offsets sales dip at PZ Cussons
28 Jul 2010
Cussons in a froth as Imperial Leather maker posts raised profits
27 Jul 2010
Icon sees results at lower end of expectations
27 Jul 2010
Israel-based company Teva Pharmaceuticals has reported an increase in profit of 53 per cent for the ...
27 Jul 2010
Calibra Gains FDA Clearance To Market Finessea Insulin Patch-Pen For Three-Day Use With Novolog
27 Jul 2010
Control Engineers Continuous Monitoring System for Larger Pharmaceutical and other Medical Products...
27 Jul 2010
Calibra Gains FDA Clearance To Market Finesse Insulin Patch-Pen For Three-Day Use With Novolog®
27 Jul 2010
Croda's half year profits soar
27 Jul 2010
INTRODUCTORY OVERVIEW OF THE PHARMACEUTICAL INDUSTRY
27 Jul 2010
GW Pharmaceuticals Plc - Directorate Change
27 Jul 2010
Croda International Plc - Interim Results
27 Jul 2010
PZ Cussons PLC - Final Results
26 Jul 2010
Comments
26 Jul 2010
Results Round-Up | Digital Look
26 Jul 2010
UPDATE: GlaxoSmithKline Pharmaceuticals 2Q Net Profit Rises 4%
26 Jul 2010
New products boost for Reckitt Benckiser profits
26 Jul 2010
Just one new approval in latest EMA opinions, generic Cellcept OK
26 Jul 2010
Israeli pharma 'in need of investment'
26 Jul 2010
Reckitt reiterates target as profit grows
26 Jul 2010
Anglo Platinum 1st Half Net Profit Up 15% On Higher Metals Prices
23 Jul 2010
SiDMAP Technology Used To Characterize Novel Drug For Type 2 Diabetes
23 Jul 2010
Neurovascular Disease: Gladstone And Lundbeck Collaboration Will Identify Novel Therapeutic Strategi...
23 Jul 2010
Q2 sales, profit improve for 3 major drugmakers
22 Jul 2010
Bristol-Myers Squibb (BMS) has reported a drop in second-quarter profit that the company attributes ...
22 Jul 2010
Abbott Laboratories has reported an unchanged net profit for the second quarter of 2010
22 Jul 2010
The Launch And Uptake Of Nine Emerging Therapies Will Drive The Prostate Cancer Drug Market To More ...
22 Jul 2010
Eli Lilly 2Q Profit Rises 16%; Bristol-Myers Profit Down 5.7%
22 Jul 2010
CORRECT: Eli Lilly 2Q Profit Jumps 16% On Higher Revenue;EPS View Raised
22 Jul 2010
UPDATE: Eli Lilly 2Q Profit Jumps 16% On Higher Revenue;EPS View Raised
22 Jul 2010
Eli Lilly 2Q Profit Jumps 16% On Higher Revenue;EPS View Raised
22 Jul 2010
Allergy Therapeutics PLC - Trading Statement
22 Jul 2010
SSL International Plc - Result of AGM
22 Jul 2010
Abbott sales climb, plots further growth in emerging markets
22 Jul 2010
Roche half-year profit rises 37 percent to $5.3B
22 Jul 2010
UPDATE: Syngenta First-Half Profit -11%; Sees Flat 2010 Profit
22 Jul 2010
Financial Director Appointed
22 Jul 2010
Reckitt pays £2.5bn for SSL to strengthen healthcare presence
22 Jul 2010
Revenues and Income Drop
22 Jul 2010
Syngenta 1st Half Profit Falls 11%; Sees Flat '10 Profit
22 Jul 2010
Revenue shortfall sends Optos shares downward
22 Jul 2010
Glaxo sees us sales stall
21 Jul 2010
Johnson & Johnson (J&J), which has been subject to
21 Jul 2010
Glaxo's 2Q Tops Expectations
21 Jul 2010
Optos third quarter revenue steady
21 Jul 2010
GSK struck down with US sales fall
21 Jul 2010
Johnson Matthey Plc - Result of AGM
21 Jul 2010
GlaxoSmithKline struggles to get past US sales slump
The chemicals, pharmaceuticals, biosciences and medical supplies sector is one of the most dynamic areas of the UK manufacturing economy and builds on Britain's traditional strengths in breakthrough scientific advance and technology innovation. It has world leadership in many fields and, in the contexts of globalisation and the gathering industrial strength and low costs base of major developing countries, continues to provide the UK with a competitive edge in high value-added knowledge based products.